AzTrials
AzTrials

Neurumusculoskeletal DisordersNCT05382117

Cardiac Rhythm and Affecting Factors in Patients Hospitalized in the Physical Therapy and Rehabilitation Clinic

An observational study of Neurumusculoskeletal Disorders, run by Trakya University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In our study, it is aimed to evaluate the cardiac rhythms of patients who are decided to receive inpatient treatment in the physical therapy and rehabilitation clinic due to any neuromusculoskeletal diseases with 24 hour rhythm holter follow up on the day of hospitalization and three weeks after hospitalization and to… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Neurumusculoskeletal Disorders
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Dec 2021to 28 Dec 2022
How long will I take part?
3 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients hospitalized in Trakya University Hospital Physiotherapy and Rehabilitation Clinic

Who may be able to join

  • Be over 18 years old
  • To be evaluated for any neuromusculoskeletal system disease and decided to be treated as an inpatient in the physical therapy and rehabilitation clinic
  • Having agreed to participate in the study

Who cannot join

  • A change in medication that may affect cardiac rhythm in the last two weeks

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Trakya University Medical Faculty

    Edirne, 22030

Other trials in Turkey (Türkiye)

About this study

In our study, it is aimed to evaluate the cardiac rhythms of patients who are decided to receive inpatient treatment in the physical therapy and rehabilitation clinic due to any neuromusculoskeletal diseases with 24 hour rhythm holter follow up on the day of hospitalization and three weeks after hospitalization and to determine the factors that may affect this result if a significant change is observed between the two measurements.The present results will guide the determination of the exercise duration, intensity, type and severity of the exercises to be created within the scope of the treatment programs of the patients and will lead to similar studies.

Read the detailed description

Neuromusculoskeletal disorders include a variety of fairly common pathologies that can have a major impact on a person's health. Today, neuromusculoskeletal diseases are the main causes of occupational diseases and chronic physical disability leading to high health care costs globally. Exercise therapy is seen as an important part of the treatment of many neuromusculoskeletal diseases.

Patients hospitalized in the physical therapy and rehabilitation clinic are generally elderly people with chronic neuromusculoskeletal system disorders. While the presence of ventricular premature beat is detected in more than 50% of healthy adults in 24 hour rhythm holter examination, this rate rises above 90% in the elderly.Although many studies have noted that regular exercise and high cardiovascular fitness reduce the risk of cardiovascular arrhythmias, exercise may paradoxically increase the risk of sudden cardiac death in those with preexisting cardiac abnormalities.

There are no studies evaluating the changes in heart rhythms during hospitalization of patients hospitalized for treatment in physical therapy and rehabilitation clinics where exercise therapy is frequently applied.In our study, it is aimed to evaluate the cardiac rhythms of patients who receive inpatient treatment in the physical therapy and rehabilitation clinic with 24 hour rhythm holter follow up on the day of hospitalization and three weeks after hospitalization and to determine the factors that may affect this result if a significant change is observed between the two measurements.

Keywords
neuromusculoskeletal, cardiovascular fitness,rhythm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evalution of the cardiac arrhythmia

    24-hour cardiac rhythm recording by holter device

    Measured: up to three weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2022
  2. Study start29 Dec 2021
  3. Primary completion28 Dec 2022 (estimated)
  4. Study completion28 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
Target duration
3 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT05382117
Sponsor's protocol ID
2021/161
Status last verified
Jun 2022
First submitted
16 May 2022
Last updated
10 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Robinson JG, Bakris G, Torner J, Stone NJ, Wallace R. Is it time for a cardiovascular primary prevention trial in the elderly? Stroke. 2007 Feb;38(2):441-50. doi: 10.1161/01.STR.0000254602.58896.d2. Epub 2006 Dec 28.

    PubMed 17194877
  • Ephrem G, Levine M, Friedmann P, Schweitzer P. The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring. Ann Noninvasive Electrocardiol. 2013 Mar;18(2):118-25. doi: 10.1111/anec.12010. Epub 2012 Nov 22.

    PubMed 23530481
  • Winkens RA, Hoppener PF, Kragten JA, Verburg MP, Crebolder HF. Are premature ventricular contractions always harmless? Eur J Gen Pract. 2014 Jun;20(2):134-8. doi: 10.3109/13814788.2013.859243. Epub 2013 Nov 28.

    PubMed 24286118
  • Frishman WH, Heiman M, Karpenos A, Ooi WL, Mitzner A, Goldkorn R, Greenberg S. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study). Am Heart J. 1996 Aug;132(2 Pt 1):297-302. doi: 10.1016/s0002-8703(96)90425-1.

    PubMed 8701890
  • Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet. 1953 Nov 28;262(6796):1111-20; concl. doi: 10.1016/s0140-6736(53)91495-0. No abstract available.

    PubMed 13110075
  • Harmon KG, Drezner JA, Wilson MG, Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Heart. 2014 Aug;100(16):1227-34. doi: 10.1136/heartjnl-2014-093872.rep.

    PubMed 25049314
  • Adrian D. Elliott , Dominik Linz, Christian V. Verdicchio, Prashanthan Sanders Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital and the South Australian Health & Medical Research Institute, 7 Adelaide, SA, Australia Heart, Lung and Circulation (2018) xx, 1--8 1443-9506/04

  • Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowicz-Wozniak B, Wrabec K. [Effect of acute exercise on cardiac arrhythmias in the course of chronic obstructive pulmonary disease]. Pneumonol Alergol Pol. 1994;62(9-10):496-500. Polish.

    PubMed 7866322
  • Manolis AS, Manolis AA. Exercise and Arrhythmias: A Double-Edged Sword. Pacing Clin Electrophysiol. 2016 Jul;39(7):748-62. doi: 10.1111/pace.12879. Epub 2016 May 25.

    PubMed 27120033

Questions about this trial

What is this clinical trial studying?

An observational study of Neurumusculoskeletal Disorders, run by Trakya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evalution of the cardiac arrhythmia (time frame: up to three weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05382117, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in